类风湿关节炎患者的睡眠障碍
在FORWARD队列4200例类风湿关节炎患者中,21%存在阻塞性睡眠呼吸暂停诊断或风险,30%有不安腿综合征症状或诊断,43%报告短睡眠;疾病活动度与每种睡眠障碍相关,阿巴西普使用与不安腿综合征和短睡眠的较低比值比相关。
要点
- 近三分之二患者符合至少一种睡眠障碍标准。
- 疾病活动度和疼痛与每种睡眠状况显著相关。
- 阿巴西普使用与不安腿综合征和短睡眠的较低比值比相关。
核心结论
- 近三分之二类风湿关节炎患者符合至少一种睡眠障碍标准,疾病活动度和疼痛与每种睡眠状况显著相关。
研究设计与样本
- 数据来自FORWARD,美国国家风湿病数据库,纳入4200例类风湿关节炎患者。
- 使用经验证的筛查工具评估阻塞性睡眠呼吸暂停风险和不安腿综合征症状,短睡眠基于自我报告平均睡眠时间少于6小时。
- 采用多变量逻辑回归模型识别睡眠障碍和睡眠质量的独立预测因素。
主要发现
- 21%(n=899)存在阻塞性睡眠呼吸暂停诊断或风险,30%(n=1,272)有不安腿综合征症状或诊断,43%(n=1,737)报告短睡眠。
- 类风湿关节炎疾病活动度与每种睡眠障碍相关。
- 阿巴西普使用与不安腿综合征和短睡眠的较低比值比相关。
- 短睡眠组使用传统改善病情抗风湿药或阿巴西普的频率较低。
- 多变量分析中无药物与阻塞性睡眠呼吸暂停相关,不安腿综合征和短睡眠均与较差的感知睡眠质量相关。
关键数值与推荐
- 阻塞性睡眠呼吸暂停诊断或风险:21%(n=899)。
- 不安腿综合征症状或诊断:30%(n=1,272)。
- 短睡眠(自我报告平均睡眠时间少于6小时):43%(n=1,737)。
- 近三分之二患者符合至少一种睡眠障碍标准。
临床怎么用
- 原文未据此给出推荐。
局限性
- 需要进一步研究以确定睡眠障碍与类风湿关节炎疾病活动度和疼痛之间的因果通路以及睡眠障碍在类风湿关节炎中的长期后果。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Self-reported sleep problems are common in rheumatoid arthritis (RA), with potential negative health implications, yet relatively little research has focused on sleep in RA. We examined the prevalence of obstructive sleep apnea (OSA) risk, restless legs syndrome (RLS) symptoms, and short sleep (SS) in a large RA cohort (n = 4,200) and factors associated with each. METHODS: Data are from FORWARD, The National Databank for Rheumatic Diseases. Validated screening measures assessed OSA risk and RLS symptoms. SS was based on self-reported average sleep time (<6 hours). The Medical Outcomes Study Sleep Problems Index I measured self-reported sleep quality. Multivariable logistic regression models identified independent predictors of sleep disorders and sleep quality and the independent association of OSA risk, RLS symptoms, and SS with self-reported poor sleep quality. RESULTS: Twenty-one percent (n = 899) had OSA diagnosis or risk, 30% (n = 1,272) had RLS symptoms or diagnosis, and 43% (n = 1,737) reported SS, and RA disease activity was associated with each sleep disorder. Abatacept use was associated with lower odds of RLS and SS. Use of conventional disease-modifying antirheumatic drugs or abatacept was less frequent in the SS group. No medications were associated with OSA in multivariable analyses. Both RLS and SS was associated with worse perceived sleep quality. DISCUSSION: Almost two-thirds met criteria for at least one sleep disorder. RA disease activity and pain were significantly associated with each sleep condition. Additional research is needed to identify the causal pathway between sleep disorders and RA disease activity and pain and the long-term consequences of sleep disorders in RA.
引用
- Katz P, Pedro S, Michaud K, et al. Sleep Disorders Among Individuals With Rheumatoid Arthritis. Arthritis Care Res (Hoboken). 2023. PMID: 35997482. doi:10.1002/acr.24999
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。